Yusen Logistics Co., Ltd. (President: Toru Kamiyama) was responsible for the international transportation of the COVID-19 vaccine of AstraZeneca Co., Ltd. (headquartered in Kita-ku, Osaka) provided to Taiwan, Vietnam, Indonesia, Thailand, the Philippines, and Malaysia through the Japanese government, from Japan to each country and region.
Yusen Logistics has invested heavily over the past 20 years in developing specialist new services and resources in global healthcare supply chain.
Company established pharmaceutical specialist teams in Japan, Americas, Europe, East Asia, and South Asia and Oceania to strengthen healthcare and pharmaceutical logistics globally.
Group is expanding operation bases complying with GDP in each country, with the aim of building a network of high-quality pharmaceutical logistics services that meet consistent standards and assure product integrity. Currently, a total of 39 operation bases in 24 countries and regions around the world are compliance with global GDP standards.
In the transportation of Healthcare products, including this time transportation of the COVID-19 vaccine, company prepared several backup plans that guarantee quality, such as routings and plants, and have formulated the optimal plan after carrying out route risk assessments to mitigate any future risks we may foresee.
As transportation and management of this vaccine is required to maintain a cold storage(2–8°C), company realize safe and reliable transportation to each country and region through cooperation with partner companies.
